A new strategy that combines two types of PET scans can guide personalized radiotherapy for head and neck cancers, according ...

A newly approved National Cancer Institute-funded clinical trial aims to improve survival for head and neck cancer patients ...

Sept. 18, 2003 — An accelerated primary radiotherapy schedule for squamous cell carcinomas of the head and neck, in which the total dose is divided into six fractions per week rather than five, ...

November 16, 2009 — Cetuximab (Erbitux) plus radiotherapy should be considered a standard option in the treatment of locoregionally advanced squamous cell carcinoma of the head and neck, say ...

The trial evaluates survival outcomes for recurrent head and neck squamous cell carcinoma post-radiation therapy, comparing ...

Please provide your email address to receive an email when new articles are posted on . Hypofractionated radiotherapy proved noninferior to conventional radiotherapy in head and neck cancer subtype.

Recent results from the phase III NRG Oncology RTOG 0920 (NRG-RTOG 0920) trial assessing postoperative radiotherapy with or without concurrent cetuximab for selected patients with squamous cell cancer ...

Patients with head and neck cancer treated with dysphagia-optimized intensity-modulated radiotherapy had improved swallow function compared with those treated with standard intensity-modulated ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window In patients with ...

Researchers believe they may have found a way to avoid damaging salivary glands during radiotherapy treatment for head and neck cancer -- a discovery that could improve the quality of life of 500,000 ...

A new strategy that combines two types of PET scans can guide personalized radiotherapy for head and neck cancers, according to new research published in The Journal of Nuclear Medicine.